Topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in Nepal: rationale and design of a randomised controlled non-inferiority trial

INTRODUCTION: Fungal infections of the cornea, fungal keratitis (FK), are challenging to treat. Current topical antifungals are not always effective and are often unavailable, particularly in low-income and middle-income countries where most cases occur. Topical natamycin 5% is usually first-line tr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open
Main Authors: Hoffman, Jeremy John, Yadav, Reena, Das Sanyam, Sandip, Chaudhary, Pankaj, Roshan, Abhishek, Singh, Sanjay Kumar, Arunga, Simon, Matayan, Einoti, Macleod, David, Weiss, Helen Anne, Leck, Astrid, Hu, Victor, Burton, Matthew J
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Ophthalmology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7528427/
https://ncbi.nlm.nih.gov/pubmed/32998924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-038066
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados